Rob Chaplinsky

Managing Director

2018

Link Ventures invests in early stage business that leverage AI, ML and data science.

Board Member, Investor

2020

Board Member, Investor

2020 - 2024

Seed Investor

2017 - 2021

Investor

2017 - 2020

Managing Director

2005 - 2018

Bridgescale is a multi-stage venture capital firm that invests in a broad sprectrum of information technology sectors. The key principals bring decades of investment and operations expertise, a vast network of Silicon Valley relationships, and a deep understanding of the high-growth technology sector. As Co-founder and Managing Director. Notable recent exits include the IPO of SaaS security company Proofpoint, the IPO of SaaS work force compensation company Xactly, the sale of IOT company Jasper to Cisco, the sale of performance HRM SaaS company Rypple to Salesforce.com, and the sale of SaaS workforce management Dayforce to Ceridian.

Investor, Advisor

2010 - 2017

Leading SaaS performance compensation software company serving thousands of customers.

Investor | Advisor | Startup Coach | Mentor | Board member | Chairman

2012 - 2016

Axonify is the world’s first Employee Knowledge Platform. Pushing beyond the boundaries of corporate eLearning, it combines an award-winning approach to micro-learning, with innovative knowledge-on-demand capabilities to ensure employees do the right things right. The entire experience is gamified, driving high levels of participation and can measure employee knowledge growth, tying it directly to behavior that powers business performance. Axonify has several fortune 100 customers is growing over 100% per year. I was the first investor in the company when it was called 17muscles and helped the management team scale the company into one of Waterloo's biggest software success stories. I resigned from the board after a private equity firm bought out my position in the company.

Investor | startup coach | advisor | mentor | stategic advisor | Board Member

2009 - 2016

BlueCat is a leading network security technology provider that enables customers to build and manage their most complex network infrastructure to meet the rapid pace of change of their business. The company is a global leader in their segment and customers include a good portion of the Fortune 100 enterprises. I invested in this company in 2009 and resigned from the board after i sold my equity position in the company to a private equity firm.

Advisor

2014 - 2016

Biolinq is pioneering computational biology technology and micro on-body biosensors for consumer and medical applications.